Finland, Denmark and Sweden are limiting the use of Moderna’s Covid-19 vaccine in young people over concerns around rare cardiovascular side effects. Finland’s national health authority, THL, announced Thursday that it would pause the use of Moderna’s Covid vaccine in young men. All males aged 30 or younger would be offered the Pfizer-BioNTech vaccine instead, THL said.

A rugged Byzantine warrior, who was decapitated following the Ottoman's capture of his fort during the 14th century, had a jaw threaded with gold, a new study finds. An analysis of the warrior's lower jaw revealed that it had been badly fractured in a previous incident, but that a talented physician had used a wire — likely gold crafted — to tie his jaw back together until it healed.

“Every time a language disappears, a speaking voice also disappears, a way to make sense of reality disappears, a way to interact with nature disappears, a way to describe and name animals and plants disappears,” says Jordi Bascompte, researcher in the Department of Evolutional Biology and Environmental Studies at the University of Zurich.

Electronic health records have been widely adopted with the hope they would save time and improve the quality of patient care. But due to fragmented interfaces and tedious data entry procedures, physicians often spend more time navigating these systems than they do interacting with patients.

Rectal Impaction Following Enema with Concrete Mix

A Covid therapy derived from a llama named Fifi has shown "significant potential" in early trials. It is a treatment made of "nanobodies", small, simpler versions of antibodies, which llamas and camels produce naturally in response to infection. Once the therapy has been tested in humans, scientists say, it could be given as a simple nasal spray - to treat and even prevent early infection.

With the iOS 15 launch today, some iPhone users will have the option to share data from their Health app directly with their doctors through their electronic medical records. Six health record companies are participating in the initial launch, and some of those companies say that doctors and medical practices on their systems are eager to start using the feature.

Hundreds of thousands of people may be infected annually by animals carrying coronaviruses related to the one that causes COVID-19 in China and Southeast Asia, according to a study emphasizing the ongoing pandemic threat from spillover events.

“We identified the probable ‘blood-to-brain pathway’ that can lead to Alzheimer’s disease, the most prevalent form of dementia globally,” said study’s senior author Professor John Mamo, director of the Curtin Health Innovation Research Institute at Curtin University.

Researchers from UNSW have uncovered how tiny anchor-like chains lock our cells in place in a new finding which could promote better cancer research and treatments in the future. In a paper published in Nature Materials earlier this month1, the researchers identified the protein chain used in these tiny anchors, called focal adhesions, which link our body’s cells to collagen, another protein which gives our body structure.

The Kidney Project’s implantable bioartificial kidney, one that promises to free kidney disease patients from dialysis machines and transplant waiting lists, took another big step toward becoming reality, earning a $650,000 prize from KidneyX for its first-ever demonstration of a functional prototype of its implantable artificial kidney.

Britain's state-run National Health Service will on Monday begin the world's biggest trial of Grail Inc's flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear.

Scientists at Oxford have demonstrated a powerful pairing – a cancer vaccine and immunotherapy. In tests in mice, the vaccine boosted levels of tumor-hunting immune cells, while the immunotherapy made them more effective killers. Human trials are due to start later this year.

There's growing demand for healthy feces from human donors to treat C. difficile and other conditions

One silver lining to the covid-19 pandemic has been the speed with which effective vaccines have been developed. Victims of other pandemics have not been so lucky. Three decades of attempts to create a vaccine against hiv, the virus that causes aids, have proved fruitless. The latest setback came on August 31st, when an experimental vaccine produced by Johnson & Johnson, an American pharmaceutical firm, flunked a clinical trial. One obstacle is hiv’s genetic slipperiness. The virus has a high mutation rate, which helps it adapt to evade both natural immune systems and artificial vaccines.

Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant. While the elderly and those who are immune-compromised may need boosters, the standard two-dose regimen is providing lasting protection for most people, she said.

The effects of ivermectin therapy on human males can have an effect on men’s reproductive health, according to a 2011 research study performed by three universities in Nigeria. Researchers at the three universities studied the effects of ivermectin, which is used to treat river blindness and other medical conditions in humans, on men’s sperm counts. According to their study, 85 percent of men who take Ivermectin become sterilized.

A cancer treatment that uses messenger RNA to launch an immune attack on cancer cells can completely shrink tumours in mice and is now being tested in people. Messenger RNAs – or mRNAs – are molecules that instruct cells to make proteins. They have risen to fame with the roll out of mRNA covid-19 vaccines.

According to the Centers for Disease Control and Prevention, approximately 1.6 million Americans have type 1 diabetes. Every year, these numbers get worse. Globally, the number of individuals living with type 1 diabetes seems to be increasing by around 3-4% annually.

With over 40 million people worldwide suffering the effects of type 1 diabetes, new efficient treatments are constantly in high demand. One technology that has great potential is the microencapsulation device (MED), which houses insulin-secreting cells in a protective compartment protecting them from the body's autoimmune response.